ST

Streamex Corp.

STEXFinancial ServicesNASDAQ

Capital Markets

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$0
-100.0% YoY
Net Income
-$462.8M
-4379.9% YoY
EBITDA
-$458.9M
-4425.5% YoY
Free Cash Flow
$12.4M

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 7 MACD Positive CrossoverHistogram +0.0255, positive momentum
Jul 6 MACD Positive CrossoverHistogram +0.0137, positive momentum
About Streamex Corp.

Streamex Corp., a medical device technology company, provides advanced digital signal processing solutions for electrophysiology in the United States. At a $172.6M market cap, Streamex Corp. ranks as a micro-cap company within financial services. The company offers the PURE EP platform, which delivers cardiac signal data to electrophysiologists during ablation procedures for the treatment of cardiovascular arrhythmias.

Where STEX stands vs its 150-day and 200-day moving averages

As of the July 7, 2026 close, STEX finished 48.34% below its 150-day moving average ($2.11) and 61.62% below its 200-day moving average ($2.84). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is STEX overbought or oversold?

At the July 7, 2026 close, STEX's RSI(14) was 56.8, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$172.6M
Fwd P/E2.45
EPS$-10.31
Beta1.94
52W Change-86.7%
ROE-625.2%
Analysis

Streamex Corp. reports $30.6M in cash and $0 in total debt. Free cash flow comes in at $12.4M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of -625.2% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has pulled back from $286K (2022) to $0 (2025), a 100% decline worth watching.

A beta of 1.94 means STEX is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. No single metric tells the full story. Reviewing STEX's risk profile alongside its fundamentals and technical indicators provides a more complete picture.

Links
More Financial Services stocks
Browse all stocks →
Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms